TapewireFind a company

organization · Reporting owner

Index Venture Associates III Ltd

Disclosed activity across 1 company

Tapewire entity
97147
SEC CIK
0001503683

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Minerva Neurosciences, Inc.

Report date June 24, 2019 · Filed June 26, 2019

Jointly reported with Index Venture Associates IV Ltd, Index Venture Associates V Ltd, Yucca (Jersey) SLP

Section 16 reporting ended · disclosed 2019-06-26. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Footnote3,899,189 Reported balance After 2019-06-24 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2019-06-24 · Sale · Disposed 197,000 · Balance 3,899,189

F1: Represents 31,147 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 69,365 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 1,236 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 47,434 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 4,502 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 37,511 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 304 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 2,501 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.26. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: Represents 675,863 shares held directly by Index III Jersey, 1,372,944 shares held directly by Index III Delaware, 24,458 shares held directly by Index III Parallel, 938,845 shares held directly by Index IV Jersey, 89,115 shares held directly by Index IV Parallel, 742,447 shares held directly by Index V Jersey, 6,016 shares held directly by Index V Parallel and 49,501 shares held directly by Yucca Jersey.

F4: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 31,147 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 69,365 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 1,236 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 47,434 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 4,502 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 37,511 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 304 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 2,501 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.26. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: Represents 675,863 shares held directly by Index III Jersey, 1,372,944 shares held directly by Index III Delaware, 24,458 shares held directly by Index III Parallel, 938,845 shares held directly by Index IV Jersey, 89,115 shares held directly by Index IV Parallel, 742,447 shares held directly by Index V Jersey, 6,016 shares held directly by Index V Parallel and 49,501 shares held directly by Yucca Jersey.

F4: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 24, 2019 Filed Jun 26, 2019 16:12 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 197,000 $6.01 $1,184,836.80
Disclosure

SEC source: 0000899243-19-018204 · doc4.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,899,189

F1 · shares: Represents 31,147 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 69,365 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 1,236 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 47,434 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 4,502 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 37,511 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 304 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 2,501 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.26. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Represents 675,863 shares held directly by Index III Jersey, 1,372,944 shares held directly by Index III Delaware, 24,458 shares held directly by Index III Parallel, 938,845 shares held directly by Index IV Jersey, 89,115 shares held directly by Index IV Parallel, 742,447 shares held directly by Index V Jersey, 6,016 shares held directly by Index V Parallel and 49,501 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 16:12 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 33,575 $4.34 $145,759.15
Disclosure

SEC source: 0000899243-19-017798 · doc4.xml · nonDerivative · entry 2

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,096,189

F5 · shares: Represents 5,818 shares sold by Index III Jersey, 11,823 shares sold by Index III Delaware, 211 shares sold by Index III Parallel, 8,084 shares sold by Index IV Jersey, 768 shares sold by Index IV Parallel, 6,395 shares sold by Index V Jersey, 51 shares sold by Index V Parallel and 425 shares sold by Yucca Jersey.

F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.25 to $4.60. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 · balance_after: Represents 710,010 shares held directly by Index III Jersey, 1,442,309 shares held directly by Index III Delaware, 25,694 shares held directly by Index III Parallel, 986,279 shares held directly by Index IV Jersey, 93,617 shares held directly by Index IV Parallel, 779,958 shares held directly by Index V Jersey, 6,320 shares held directly by Index V Parallel and 52,002 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 19, 2019 Filed Jun 21, 2019 16:12 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 77,243 $4.44 $343,152.03
Disclosure

SEC source: 0000899243-19-017798 · doc4.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,129,764

F1 · shares: Represents 13,389 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 27,198 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 484 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 18,599 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 1,765 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 14,708 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 119 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 981 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.31 to $4.555. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Represents 715,828 shares held directly by Index III Jersey, 1,454,132 shares held directly by Index III Delaware, 25,905 shares held directly by Index III Parallel, 994,363 shares held directly by Index IV Jersey, 94,385 shares held directly by Index IV Parallel, 786,353 shares held directly by Index V Jersey, 6,371 shares held directly by Index V Parallel and 52,427 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 18, 2019 Filed Jun 19, 2019 16:10 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 49,675 $4.44 $220,522.23
Disclosure

SEC source: 0000899243-19-017418 · doc4.xml · nonDerivative · entry 2

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,207,007

F5 · shares: Represents 8,610 shares sold by Index III Jersey, 17,491 shares sold by Index III Delaware, 311 shares sold by Index III Parallel, 11,961 shares sold by Index IV Jersey, 1,135 shares sold by Index IV Parallel, 9,459 shares sold by Index V Jersey, 77 shares sold by Index V Parallel and 631 shares sold by Yucca Jersey.

F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.51. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 · balance_after: Represents 729,217 shares held directly by Index III Jersey, 1,481,330 shares held directly by Index III Delaware, 26,389 shares held directly by Index III Parallel, 1,012,962 shares held directly by Index IV Jersey, 96,150 shares held directly by Index IV Parallel, 801,061 shares held directly by Index V Jersey, 6,490 shares held directly by Index V Parallel and 53,408 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 17, 2019 Filed Jun 19, 2019 16:10 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 56,243 $4.45 $250,208.23
Disclosure

SEC source: 0000899243-19-017418 · doc4.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,256,682

F1 · shares: Represents 9,749 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 19,804 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 353 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 13,542 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 1,285 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 10,709 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 87 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 714 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.365 to $4.55. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Represents 737,827 shares held directly by Index III Jersey, 1,498,821 shares held directly by Index III Delaware, 26,700 shares held directly by Index III Parallel, 1,024,923 shares held directly by Index IV Jersey, 97,285 shares held directly by Index IV Parallel, 810,520 shares held directly by Index V Jersey, 6,567 shares held directly by Index V Parallel and 54,039 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 14, 2019 Filed Jun 17, 2019 16:26 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 25,169 $4.50 $113,187.51
Disclosure

SEC source: 0000899243-19-017189 · doc4.xml · nonDerivative · entry 2

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,312,925

F5 · shares: Represents 4,363 shares sold by Index III Jersey, 8,862 shares sold by Index III Delaware, 158 shares sold by Index III Parallel, 6,060 shares sold by Index IV Jersey, 575 shares sold by Index IV Parallel, 4,792 shares sold by Index V Jersey, 39 shares sold by Index V Parallel and 320 shares sold by Yucca Jersey.

F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.60. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 · balance_after: Represents 747,576 shares held directly by Index III Jersey, 1,518,625 shares held directly by Index III Delaware, 27,053 shares held directly by Index III Parallel, 1,038,465 shares held directly by Index IV Jersey, 98,570 shares held directly by Index IV Parallel, 821,229 shares held directly by Index V Jersey, 6,654 shares held directly by Index V Parallel and 54,753 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 16:26 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 53,298 $4.51 $240,549.86
Disclosure

SEC source: 0000899243-19-017189 · doc4.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,338,094

F1 · shares: Represents 9,238 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 18,767 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 334 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 12,833 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 1,218 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 10,148 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 83 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 677 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.595. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Represents 751,939 shares held directly by Index III Jersey, 1,527,487 shares held directly by Index III Delaware, 27,211 shares held directly by Index III Parallel, 1,044,525 shares held directly by Index IV Jersey, 99,145 shares held directly by Index IV Parallel, 826,021 shares held directly by Index V Jersey, 6,693 shares held directly by Index V Parallel and 55,073 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 12, 2019 Filed Jun 13, 2019 16:55 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 26,901 $4.57 $122,988.68
Disclosure

SEC source: 0000899243-19-016830 · doc4.xml · nonDerivative · entry 2

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,391,392

F5 · shares: Represents 4,663 shares sold by Index III Jersey, 9,472 shares sold by Index III Delaware, 169 shares sold by Index III Parallel, 6,477 shares sold by Index IV Jersey, 615 shares sold by Index IV Parallel, 5,122 shares sold by Index V Jersey, 41 shares sold by Index V Parallel and 342 shares sold by Yucca Jersey.

F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.63. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 · balance_after: Represents 761,177 shares held directly by Index III Jersey, 1,546,254 shares held directly by Index III Delaware, 27,545 shares held directly by Index III Parallel, 1,057,358 shares held directly by Index IV Jersey, 100,363 shares held directly by Index IV Parallel, 836,169 shares held directly by Index V Jersey, 6,776 shares held directly by Index V Parallel and 55,750 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 11, 2019 Filed Jun 13, 2019 16:55 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 33,150 $4.78 $158,354.24
Disclosure

SEC source: 0000899243-19-016830 · doc4.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,418,293

F1 · shares: Represents 5,746 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 11,672 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 208 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 7,982 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 758 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 6,312 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 51 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 421 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.95. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Represents 765,840 shares held directly by Index III Jersey, 1,555,726 shares held directly by Index III Delaware, 27,714 shares held directly by Index III Parallel, 1,063,835 shares held directly by Index IV Jersey, 100,978 shares held directly by Index IV Parallel, 841,291 shares held directly by Index V Jersey, 6,817 shares held directly by Index V Parallel and 56,092 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
May 20, 2019 Filed May 21, 2019 16:10 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 200 $6.08 $1,215.00
Disclosure

SEC source: 0000899243-19-014268 · doc4.xml · nonDerivative · entry 2

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,451,443

F5 · shares: Represents 35 shares sold by Index III Jersey, 70 shares sold by Index III Delaware, 1 share sold by Index III Parallel, 48 shares sold by Index IV Jersey, 5 shares sold by Index IV Parallel, 38 shares sold by Index V Jersey, 0 shares sold by Index V Parallel and 3 shares sold by Yucca Jersey.

F6 · balance_after: Represents 771,586 shares held directly by Index III Jersey, 1,567,398 shares held directly by Index III Delaware, 27,922 shares held directly by Index III Parallel, 1,071,817 shares held directly by Index IV Jersey, 101,736 shares held directly by Index IV Parallel, 847,603 shares held directly by Index V Jersey, 6,868 shares held directly by Index V Parallel and 56,513 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
May 17, 2019 Filed May 21, 2019 16:10 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 22,718 $6.02 $136,680.58
Disclosure

SEC source: 0000899243-19-014268 · doc4.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,451,643

F1 · shares: Represents 3,938 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 7,999 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 143 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 5,470 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 519 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 4,326 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 35 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 288 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.25. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Represents 771,621 shares held directly by Index III Jersey, 1,567,468 shares held directly by Index III Delaware, 27,923 shares held directly by Index III Parallel, 1,071,865 shares held directly by Index IV Jersey, 101,741 shares held directly by Index IV Parallel, 847,641 shares held directly by Index V Jersey, 6,868 shares held directly by Index V Parallel and 56,516 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
May 16, 2019 Filed May 16, 2019 18:09 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 44,836 $6.37 $285,672.57
Disclosure

SEC source: 0000899243-19-013815 · doc4.xml · nonDerivative · entry 3

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,474,361

F8 · shares: Represents 7,772 shares sold by Index III Jersey, 15,787 shares sold by Index III Delaware, 281 shares sold by Index III Parallel, 10,796 shares sold by Index IV Jersey, 1,025 shares sold by Index IV Parallel, 8,537 shares sold by Index V Jersey, 69 shares sold by Index V Parallel and 569 shares sold by Yucca Jersey.

F9 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.26 to $6.525. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10 · balance_after: Represents 775,559 shares held directly by Index III Jersey, 1,575,467 shares held directly by Index III Delaware, 28,066 shares held directly by Index III Parallel, 1,077,335 shares held directly by Index IV Jersey, 102,260 shares held directly by Index IV Parallel, 851,967 shares held directly by Index V Jersey, 6,903 shares held directly by Index V Parallel and 56,804 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
May 15, 2019 Filed May 16, 2019 18:09 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 53,418 $6.64 $354,465.82
Disclosure

SEC source: 0000899243-19-013815 · doc4.xml · nonDerivative · entry 2

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,519,197

F5 · shares: Represents 9,259 shares sold by Index III Jersey, 18,809 shares sold by Index III Delaware, 335 shares sold by Index III Parallel, 12,862 shares sold by Index IV Jersey, 1,221 shares sold by Index IV Parallel, 10,171 shares sold by Index V Jersey, 83 shares sold by Index V Parallel and 678 shares sold by Yucca Jersey.

F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.79. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 · balance_after: Represents 783,331 shares held directly by Index III Jersey, 1,591,254 shares held directly by Index III Delaware, 28,347 shares held directly by Index III Parallel, 1,088,131 shares held directly by Index IV Jersey, 103,285 shares held directly by Index IV Parallel, 860,504 shares held directly by Index V Jersey, 6,972 shares held directly by Index V Parallel and 57,373 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
May 14, 2019 Filed May 16, 2019 18:09 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 36,574 $7.05 $258,022.26
Disclosure

SEC source: 0000899243-19-013815 · doc4.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,572,615

F1 · shares: Represents 6,340 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 12,878 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 229 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 8,806 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 836 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 6,964 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 57 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 464 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.78 to $7.41. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Represents 792,590 shares held directly by Index III Jersey, 1,610,063 shares held directly by Index III Delaware, 28,682 shares held directly by Index III Parallel, 1,100,993 shares held directly by Index IV Jersey, 104,506 shares held directly by Index IV Parallel, 870,675 shares held directly by Index V Jersey, 7,055 shares held directly by Index V Parallel and 58,051 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 12:38 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 15,444 $12.35 $190,747.30
Disclosure

SEC source: 0000899243-18-025985 · doc4.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,609,189

F1 · shares: Represents 2,677 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 5,438 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 97 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 3,718 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 353 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 2,941 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 24 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 196 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.80. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Represents 798,930 shares held directly by Index III Jersey, 1,622,941 shares held directly by Index III Delaware, 28,911 shares held directly by Index III Parallel, 1,109,799 shares held directly by Index IV Jersey, 105,342 shares held directly by Index IV Parallel, 877,639 shares held directly by Index V Jersey, 7,112 shares held directly by Index V Parallel and 58,515 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
September 28, 2018 Filed Oct 1, 2018 14:14 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 34,589 $12.62 $436,343.69
Disclosure

SEC source: 0000899243-18-025642 · doc4.xml · nonDerivative · entry 2

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,624,633

F5 · shares: Represents 5,996 shares sold by Index III Jersey, 12,179 shares sold by Index III Delaware, 217 shares sold by Index III Parallel, 8,328 shares sold by Index IV Jersey, 791 shares sold by Index IV Parallel, 6,586 shares sold by Index V Jersey, 53 shares sold by Index V Parallel and 439 shares sold by Yucca Jersey.

F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.45 to $12.75. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 · balance_after: Represents 801,607 shares held directly by Index III Jersey, 1,628,379 shares held directly by Index III Delaware, 29,008 shares held directly by Index III Parallel, 1,113,517 shares held directly by Index IV Jersey, 105,695 shares held directly by Index IV Parallel, 880,580 shares held directly by Index V Jersey, 7,136 shares sold by Index V Parallel and 58,711 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose

Read SEC document
September 27, 2018 Filed Oct 1, 2018 14:14 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 SaleCommon Stock 31,684 $12.57 $398,274.22
Disclosure

SEC source: 0000899243-18-025642 · doc4.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,659,222

F1 · shares: Represents 5,492 shares sold by Index Ventures III (Jersey), L.P. ("Index III Jersey"), 11,156 shares sold by Index Ventures III (Delaware), L.P. ("Index III Delaware"), 199 shares sold by Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. ("Index III Parallel" and, together with Index III Jersey and Index III Delaware, the "Index III Funds"), 7,629 shares sold by Index Ventures IV (Jersey) L.P. ("Index IV Jersey"), 724 shares sold by Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. ("Index IV Parallel" and, together with Index IV Jersey, the "Index IV Funds"), 6,033 shares sold by Index Ventures V (Jersey), L.P. ("Index V Jersey"), 49 shares sold by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. ("Index V Parallel" and, together with Index V Jersey, the "Index V Funds") and 402 shares sold by Yucca (Jersey) SLP ("Yucca Jersey").

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.375 to $12.95. The reporting persons undertake to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Represents 807,603 shares held directly by Index III Jersey, 1,640,558 shares held directly by Index III Delaware, 29,225 shares held directly by Index III Parallel, 1,121,845 shares held directly by Index IV Jersey, 106,486 shares held directly by Index IV Parallel, 887,166 shares held directly by Index V Jersey, 7,189 shares sold by Index V Parallel and 59,150 shares held directly by Yucca Jersey.

F4 · ownership.nature: Index Venture Associates III Ltd. ("Index III GP") is the general partner of the Index III Funds, Index Venture Associates IV Ltd. ("Index IV GP") is the general partner of the Index IV Funds and Index Venture Associates V Ltd. ("Index V GP") is the general partner of the Index V Funds. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Intertrust Employee Benefit Services Limited. Each of Index III GP, Index IV GP and Index V GP disclaims Section 16 beneficial ownership of the securities held by the Index III Funds, Index IV Funds and Index V Funds, respectively, and the shares held by Yucca Jersey, except to the extent of its respective pecuniary interest therein, if any, and this report shall not be deemed an admission that Index III GP, Index IV GP or Index V GP is the beneficial owner of such securities for Section 16 or any other purpose

Read SEC document
December 12, 2016 Filed Dec 14, 2016 14:17 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 OtherWarrant Shares · Derivative 202,634 $0.00 Strike: $5.77 $0.00
Disclosure

SEC source: 0001140361-16-089635 · doc1.xml · derivative · entry 2

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Shares · 202,634 shares

Expires 2017-03-18

F4 · shares: Composed of 35,376 warrant shares exercised by Index Ventures III (Jersey), L.P., 71,862 warrant shares exercised by Index Ventures III (Delaware), L.P., 1,280 warrant shares exercised by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 warrant shares exercised by Index Ventures IV (Jersey), L.P., 4,631 warrant shares exercised by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 warrant shares exercised by Index Ventures V (Jersey), L.P., 313 warrant shares exercised by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 warrant shares exercised by Yucca (Jersey) SLP.

F2 · derivative.underlying_shares: Composed of 35,376 common shares acquired by Index Ventures III (Jersey), L.P., 71,862 common shares acquired by Index Ventures III (Delaware), L.P., 1,280 common shares acquired by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 common shares acquired by Index Ventures IV (Jersey), L.P., 4,631 common shares acquired by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 common shares acquired by Index Ventures V (Jersey), L.P., 313 common shares acquired by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 common shares acquired by Yucca (Jersey) SLP.

F1 · ownership.nature: Index Venture Associates III Limited is the general partner of Index Ventures III (Jersey), L.P., Index Ventures III (Delaware), L.P., and Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Elian Employee Benefit Services Limited. Index Venture Associates IV Limited is the general partner of Index Ventures IV (Jersey) L.P. and Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. Index Venture Associates V Limited is the general partner of Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. and Index Ventures V (Jersey), L.P.

F3 · ownership.nature: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP.

F5 · ownership.nature: Michele Ollier, Director of the Issuer, is a partner of Medicxi Ventures (Jersey) Limited Succursale de Geneve which provides sub-advisory services to the foregoing funds and Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein. Francesco De Rubertis, Director of the Issuer, is a partner of Medicxi Ventures (UK) LLP which provides sub-advisory services to the foregoing funds and Dr. De Rubertis disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of his proportionate pecuniary interest therein. Index Venture Associates III Limited, Index Venture Associates IV Limited, Index Venture Associates V Limited and Yucca (Jersey) SLP (collectively, the "Index Entities") are members of a "group" for purposes of Section 13(d) of the Exchange Act.

F6 · ownership.nature: This Statement Form 4 is being filed jointly by the Index Entities. Each of the Index Entities disclaims beneficial ownership held of record by any of the other Index Entities, except to the extent of their respective proportionate pecuniary interest(s) therein.

Read SEC document
December 12, 2016 Filed Dec 14, 2016 14:17 UTC Minerva Neurosciences, Inc. NERV · Entity 6245 OtherCommon Stock 202,634 $5.77 $1,169,603.45
Disclosure

SEC source: 0001140361-16-089635 · doc1.xml · nonDerivative · entry 1

Index Venture Associates III Ltd · CIK 0001503683 · 10% owner

Index Venture Associates IV Ltd · CIK 0001447962 · 10% owner

Index Venture Associates V Ltd · CIK 0001611751 · 10% owner

Yucca (Jersey) SLP · CIK 0001591294 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 4,690,906

F2 · shares: Composed of 35,376 common shares acquired by Index Ventures III (Jersey), L.P., 71,862 common shares acquired by Index Ventures III (Delaware), L.P., 1,280 common shares acquired by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 48,790 common shares acquired by Index Ventures IV (Jersey), L.P., 4,631 common shares acquired by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 38,584 common shares acquired by Index Ventures V (Jersey), L.P., 313 common shares acquired by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 1,798 common shares acquired by Yucca (Jersey) SLP.

F3 · balance_after: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP.

F1 · ownership.nature: Index Venture Associates III Limited is the general partner of Index Ventures III (Jersey), L.P., Index Ventures III (Delaware), L.P., and Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. Yucca (Jersey) SLP is the Administrator of the Index Co-Investment Scheme acting through Elian Employee Benefit Services Limited. Index Venture Associates IV Limited is the general partner of Index Ventures IV (Jersey) L.P. and Index Ventures IV Parallel Entrepreneur Fund (Jersey) L.P. Index Venture Associates V Limited is the general partner of Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. and Index Ventures V (Jersey), L.P.

F3 · ownership.nature: Composed of 813,095 common shares held by Index Ventures III (Jersey), L.P., 1,651,714 common shares held by Index Ventures III (Delaware), L.P., 29,424 common shares held by Index Ventures III Parallel Entrepreneur Fund (Jersey), L.P., 1,129,474 common shares held by Index Ventures IV (Jersey), L.P., 107,210 common shares held by Index Ventures IV Parallel Entrepreneur Fund (Jersey), L.P., 893,199 common shares held by Index Ventures V (Jersey), L.P., 7,238 common shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P., and 59,552 common shares held by Yucca (Jersey) SLP.

F5 · ownership.nature: Michele Ollier, Director of the Issuer, is a partner of Medicxi Ventures (Jersey) Limited Succursale de Geneve which provides sub-advisory services to the foregoing funds and Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein. Francesco De Rubertis, Director of the Issuer, is a partner of Medicxi Ventures (UK) LLP which provides sub-advisory services to the foregoing funds and Dr. De Rubertis disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of his proportionate pecuniary interest therein. Index Venture Associates III Limited, Index Venture Associates IV Limited, Index Venture Associates V Limited and Yucca (Jersey) SLP (collectively, the "Index Entities") are members of a "group" for purposes of Section 13(d) of the Exchange Act.

F6 · ownership.nature: This Statement Form 4 is being filed jointly by the Index Entities. Each of the Index Entities disclaims beneficial ownership held of record by any of the other Index Entities, except to the extent of their respective proportionate pecuniary interest(s) therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.